ArticleAmerican journal of translational research2021
The application of lacrimal duct endoscopy in the diagnosis and treatment of lacrimal canaliculitis and obstructive diseases of the nasolacrimal duct.
Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the clinical effectiveness and value of lacrimal duct endoscopy in lacrimal canaliculitis and nasolacrimal duct obstruction diseases.
methodsWe retrospectively analyzed 241 patients with lacrimal canaliculitis and nasolacrimal duct obstructions admitted to our hospital from January 2019 to June 2020. Among them, 165 patients underwent routine diagnosis and treatment and 76 patients underwent lacrimal duct endoscopy. The propensity score matching 1:1 nearest neighbor matching method was used to match 50 patients from each of the two methods to create a control group and an experimental group, respectively. We compared the two groups' effective treatment rates, incidences of adverse reactions, diagnostic accuracy, and IL-6, IL-8, and CRP expression levels.
resultsin contrast with the control group, we observed a significantly higher effective treatment rate in the experimental group (P<0.05). The experimental group had a significantly better reactions rate than the control group (P<0.05). In terms of the diagnostic accuracy rate, the experimental group's results were much better (P<0.05). The IL-6, IL-8, and CRP expression levels in the experimental group were much lower in the comparison with the control group (P<0.05).
conclusionLacrimal duct endoscopic diagnosis and treatment can significantly enhance the treatment efficiency and diagnostic accuracy in lacrimal canaliculitis and nasolacrimal duct obstruction patients and can help reduce adverse reactions and the IL-6, IL-8, and CRP expression levels during the treatment. Therefore, lacrimal duct endoscopy has a high clinical effectiveness in lacrimal canaliculitis and nasolacrimal duct obstruction patients.
Indexed as
Identifiers
34540056PMC8430144W3200548162What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.